By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ARUP Laboratories will begin offering Decode Genetics' prostate cancer test in the fall under a deal announced today.

ARUP will offer Decode's ProstateCancer test to academic medical centers, public and private healthcare providers, and major hospitals in the US as part of its portfolio of tests. The test will be ordered through ARUP, which will handle patient samples and results. Decode will analyze the samples in its CAP and CLIA-certified laboratory.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.